the emerging role of mrd in colorectal cancer decision making
Published 1 year ago • 379 plays • Length 2:53Download video MP4
Download video MP3
Similar videos
-
2:27
the current state of mrd testing in colorectal cancer
-
1:19
how can we implement mrd testing in colorectal cancer?
-
7:53
ctdna mrd detection from plasma and urine in colorectal cancer
-
2:33
the critical role of minimal residual disease (mrd) throughout the cancer care journey 1080p
-
8:45
ctdna as a novel biomarker for mrd in crc
-
22:46
mutational testing and the treatment of colorectal cancer
-
8:04
“circulate” clinical trial evaluating ctdna dynamics and clinical outcomes in colon cancer
-
1:07
updates in adjuvant and neoadjuvant treatment for colon cancer
-
1:44
cxcr1/2 and pd-1 inhibition in ctdna positive and ras-mutant crc
-
15:23
2021 west oncology | gastrointestinal cancers | ctdna analysis in colorectal cancer
-
5:44
the future of mrd assessment in crc
-
1:05:21
ctdna and mrd testing | colorectal cancer care tools for surveillance
-
1:12
targeted therapies in metastatic colorectal cancer
-
24:05
what's new in colorectal cancer treatment? by michael hall, md, ms
-
2:20
updates from the circulate-us trial
-
2:34
crt-induced molecular alterations and associated outcomes in patients with rectal cancer
-
1:52:25
management of advanced colorectal cancer disease.
-
4:11
using ctcs to determine minimal residual disease in gi cancers
-
2:16
how does colorectal cancer develop?